Physician profile
Vera U Abaaba
NPI 1033401856
$950.52
in general payments reported to CMS, 2019-2025
16 companies · $156 in 2025
The $156 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $75.38 · 2021: $68.61 · 2022: $36.18 · 2023: $184 · 2024: $244 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $584.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $152.04 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $132.11 | 2022-2024 | Wainua, Andexxa, Lokelma |
| Merck Sharp & Dohme LLC | $99.97 | 2019-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $94.77 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $71.78 | 2019-2025 | Camzyos |
| Alexion Pharmaceuticals, INC. | $70.60 | 2019-2023 | Ultomiris |
| Aimmune Therapeutics, INC. | $67.18 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $58.94 | 2020-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.25 | 2024-2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.06 | 2025 | Jardiance |
| Allergan, INC. | $29.94 | 2019-2020 | |
| Ucb, INC. | $22.90 | 2019 | |
| Mallinckrodt Hospital Products INC. | $17.89 | 2023 | Terlivaz |
| Lexicon Pharmaceuticals, INC. | $16.10 | 2024 | Inpefa |
| Pfizer INC. | $15.70 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14.29 | 2024 | Kyphon Express II Kyphopak Tray |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vera Abaaba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.